GC
GRX

Guggenheim Capital’s Gabelli Healthcare & Wellness Trust GRX Stock Holding History

Guggenheim Capital’s Portfolio GRX Stock Details GRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-11,477
Closed -$123K – 1964
2022
Q2 		$123K Sell
11,477
-12,355
-52% -$143K ﹤0.01% 1998
2022
Q1 		$305K Sell
23,832
-8,589
-26% -$110K ﹤0.01% 1881
2021
Q4 		$440K Buy
32,421
+90
+0.3% +$1.19K ﹤0.01% 1741
2021
Q3 		$427K Buy
32,331
+7,095
+28% +$96.1K ﹤0.01% 1809
2021
Q2 		$341K Buy
25,236
+3,713
+17% +$48.8K ﹤0.01% 1980
2021
Q1 		$268K Sell
21,523
-4,917
-19% -$60.3K ﹤0.01% 1997
2020
Q4 		$315K Sell
26,440
-3,863
-13% -$42.8K ﹤0.01% 1810
2020
Q3 		$313K Buy
30,303
+13,380
+79% +$140K ﹤0.01% 1620
2020
Q2 		$170K Buy
+16,923
New +$168K ﹤0.01% 1778
2018
Q4 		– Sell
-14,641
Closed -$161K – 2250
2018
Q3 		$161K Buy
14,641
+3,429
+31% +$36.5K ﹤0.01% 2349
2018
Q2 		$112K Buy
+11,212
New +$109K ﹤0.01% 2345
2017
Q2 		– Sell
-50,047
Closed -$500K – 2843
2017
Q1 		$500K Sell
50,047
-6,808
-12% -$67.6K ﹤0.01% 2378
2016
Q4 		$536K Buy
56,855
+3,544
+7% +$34.5K ﹤0.01% 2397
2016
Q3 		$555K Sell
53,311
-70
-0.1% -$765 ﹤0.01% 2351
2016
Q2 		$570K Buy
53,381
+2,781
+5% +$28.6K ﹤0.01% 2318
2016
Q1 		$498K Sell
50,600
-889
-2% -$8.5K ﹤0.01% 2366
2015
Q4 		$528K Buy
51,489
+21,581
+72% +$219K ﹤0.01% 2430
2015
Q3 		$290K Buy
29,908
+7,674
+35% +$83.6K ﹤0.01% 2605
2015
Q2 		$250K Buy
22,234
+342
+2% +$3.85K ﹤0.01% 2752
2015
Q1 		$247K Sell
21,892
-20,500
-48% -$221K ﹤0.01% 2745
2014
Q4 		$442K Hold
42,392
– – ﹤0.01% 2568
2014
Q3 		$420K Buy
42,392
+14,672
+53% +$148K ﹤0.01% 2623
2014
Q2 		$287K Sell
27,720
-970
-3% -$9.77K ﹤0.01% 2784
2014
Q1 		$287K Sell
28,690
-272
-0.9% -$2.72K ﹤0.01% 2760
2013
Q4 		$290K Hold
28,962
– – ﹤0.01% 2727
2013
Q3 		$279K Hold
28,962
– – ﹤0.01% 2630
2013
Q2 		$274K Buy
+28,962
New +$288K ﹤0.01% 2646

Other funds holding GRX

Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
Lazard Asset Management
Lazard Asset Management New York $60.8B AUM 22.47% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
GI
GAMCO Investors Greenwich, Connecticut $10.2B AUM 30.27% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
ACP
Aviance Capital Partners Naples, Florida $854M AUM 25.16% 1-Year Est. Return
Cetera Investment Advisers
Cetera Investment Advisers Schaumburg, Illinois $94B AUM 20.14% 1-Year Est. Return
BA
Bennicas & Associates Portola Valley, California $173M AUM 1.55% 1-Year Est. Return
WAP
Wealthcare Advisory Partners West Chester, Pennsylvania $5.27B AUM 22.23% 1-Year Est. Return

Guggenheim Capital's GRX Position: Q3 2022 in Review

Guggenheim Capital sold out of Gabelli Healthcare & Wellness Trust (GRX) in Q3 2022, closing a stake of 11,477 shares — an estimated $123K sold.

Guggenheim Capital first reported a position in GRX in Q2 2013 and held it in 27 quarters. The position peaked at $570K in Q2 2016. 65 funds tracked by Wall St. Rank hold GRX as of Q3 2022.

  • Guggenheim Capital reported no remaining Gabelli Healthcare & Wellness Trust position as of Q3 2022 after selling out during the quarter.
  • Guggenheim Capital sold 11,477 Gabelli Healthcare & Wellness Trust shares in Q3 2022, an estimated $123K.
  • Guggenheim Capital first reported a position in Gabelli Healthcare & Wellness Trust in Q2 2013 and held it in 27 quarters.
  • Guggenheim Capital's Gabelli Healthcare & Wellness Trust position peaked at $570K in Q2 2016.
  • 65 funds tracked by Wall St. Rank held Gabelli Healthcare & Wellness Trust as of Q3 2022.

Based on Guggenheim Capital's 13F filing for Q3 2022, filed 14 Nov 2022.